BRIEF published on 02/19/2025 at 19:15, 1 year 8 months ago Aspire Biopharma Begins Trading on Nasdaq Following Merger Nasdaq Listing Business Combination Public Offering Drug Delivery Technology Aspire Biopharma
BRIEF published on 02/19/2025 at 19:15, 1 year 8 months ago Aspire Biopharma commence à être cotée au Nasdaq après sa fusion Technologie D'administration De Médicaments Cotation Au Nasdaq Regroupement D’entreprises Offre Publique De Vente Aspire Biopharma
PRESS RELEASE published on 02/19/2025 at 19:10, 1 year 8 months ago Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq Aspire Biopharma and PowerUp Acquisition Corp. completed their business combination, enhancing access to capital and new product development. Shares to trade on Nasdaq as ASBP and ASBPW Nasdaq Business Combination Aspire Biopharma PowerUp Acquisition Corp. Drug Delivery Mechanism
Published on 11/04/2026 at 23:10, 8 hours 8 minutes ago Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 8 hours 18 minutes ago Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 9 hours 3 minutes ago Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 9 hours 13 minutes ago Stabilis Solutions Announces Third Quarter 2026 Results
Published on 11/05/2026 at 07:05, 13 minutes ago PolyPeptide Group: Definitive end result of the public tender offer of Samsung Biologics Co., Ltd.
Published on 11/05/2026 at 07:05, 13 minutes ago EDAG Engineering Group AG: Profitability significantly improved in the first nine months of 2026
Published on 11/05/2026 at 07:02, 16 minutes ago Commerzbank delivers best nine-month result in its history
Published on 11/05/2026 at 07:00, 17 minutes ago Private Equity Holding AG: Half Year-Report as of September 30, 2026
Published on 11/05/2026 at 07:00, 17 minutes ago Rational continues on growth trajectory and confirms profit forecast for 2026
Published on 11/05/2026 at 07:00, 18 minutes ago Accélération confirmée au troisième trimestre 2026 Tous les métiers en croissance, chiffre d’affaires en progression de +6,5 %
Published on 11/05/2026 at 07:00, 18 minutes ago Eurazeo’s European asset management platform continues to gain momentum, driven by sustained international fundraising
Published on 11/05/2026 at 07:00, 18 minutes ago Growth acceleration confirmed in the third quarter of 2026 All businesses growing, revenue up +6,5%
Published on 11/05/2026 at 07:00, 18 minutes ago Eurazeo confirme la dynamique de sa plateforme européenne de gestion d’actifs, portée par une collecte internationale soutenue
Published on 11/04/2026 at 18:00, 13 hours 17 minutes ago The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
